These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 14564303)

  • 1. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
    Direct Thrombin Inhibitor Trialists' Collaborative Group
    Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct thrombin inhibitors in cardiac disease.
    Weitz JI; Bates ER
    Cardiovasc Toxicol; 2003; 3(1):13-25. PubMed ID: 12668887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinician update: direct thrombin inhibitors in acute coronary syndromes.
    Wykrzykowska JJ; Kathiresan S; Jang IK
    J Thromb Thrombolysis; 2003 Feb; 15(1):47-57. PubMed ID: 14574076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin, an ideal target for pharmacological inhibition: a review of direct thrombin inhibitors.
    Gurm HS; Bhatt DL
    Am Heart J; 2005 Jan; 149(1 Suppl):S43-53. PubMed ID: 15644793
    [No Abstract]   [Full Text] [Related]  

  • 7. Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.
    Bates ER
    Curr Cardiol Rep; 2001 Sep; 3(5):348-54. PubMed ID: 11504570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct thrombin inhibitors in acute coronary syndromes.
    Jang IK
    Lancet; 2002 Aug; 360(9331):491-2; author reply 492. PubMed ID: 12241752
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial.
    Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E;
    J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct thrombin antagonists].
    Lankes W; Fleischer K; Gulba DC
    Herz; 2001 Apr; 26 Suppl 1():46-52. PubMed ID: 11349627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine.
    Wong CK; White HD
    Am J Cardiovasc Drugs; 2007; 7(4):249-57. PubMed ID: 17696566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hirudin in acute coronary syndromes.
    van de Loo A; Bode C
    Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
    Kleiman NS
    Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of thrombin inhibition during percutaneous coronary intervention.
    Wittkowsky AK
    Pharmacotherapy; 2002 Jun; 22(6 Pt 2):97S-104S. PubMed ID: 12064571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of direct thrombin inhibitors in acute coronary syndromes.
    Eikelboom J; White H; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):70S-78S. PubMed ID: 12644344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial results with hirudin and bivalirudin for acute coronary artery syndromes.
    Bates ER
    Semin Thromb Hemost; 1997; 23(6):575-81. PubMed ID: 9469633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.